[go: up one dir, main page]

GT199900219A - CCR5 MODULATORS - Google Patents

CCR5 MODULATORS

Info

Publication number
GT199900219A
GT199900219A GT199900219A GT199900219A GT199900219A GT 199900219 A GT199900219 A GT 199900219A GT 199900219 A GT199900219 A GT 199900219A GT 199900219 A GT199900219 A GT 199900219A GT 199900219 A GT199900219 A GT 199900219A
Authority
GT
Guatemala
Prior art keywords
compounds
dosage forms
ccr5
modulators
formulations
Prior art date
Application number
GT199900219A
Other languages
Spanish (es)
Inventor
Duncan Robert Armour
David Anthony Price
Blanda Luzia Christa Stammen
Anthony Wood
Manoussos Perros
Martin Paul Edwards
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT199900219A publication Critical patent/GT199900219A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

ESTA INVENCION SE REFIERE A NUEVOS COMPUESTOS QUIMICOS, (ESTRUCTURA QUE SE MUESTRA COMO "FORMULA I ", DICHA ESTRUCTURA ESTA ESCINDIDA EN CUATRO REGIONES PARA SU MEJOR COMPRENSION, LAS QUE SE MUESTRAN EN EL EXPEDIENTE ORIGINAL). ESTOS COMPUESTOS ENCUENTRAN UN USO PARTICULAR, AUNQUE NO EXCLUSIVO, COMO COMPUESTOS FARMACEUTICOS, ESPECIALMENTE COMO MODULADORES DE CCR5 DE QUIMIOCINAS (CITOCINAS QUIMIOTACTICAS). TAMBIEN SE REFIERE A FORMULACIONES O FORMAS DE DOSIFICACION QUE INCLUYEN ESTOS COMPUESTOS, AL USO DE ESTOS COMPUESTOS EN LA FABRICACION DE FORMULACIONES FARMACEUTICAS O FORMAS DE DOSIFICACION Y A PROCEDIMIENTOS DE TRATAMIENTO, ESPECIALMENTE EL TRATAMIENTO DE ENFERMEDADES Y AFECCIONES ANTIINFLAMATORES Y EL TRATAMIENTO Y PREVENCION DE INFECCIONES PRODUCIDAS POR VIH1 Y POR RETROVIRUS RELACIONADOS GENETICAMENTE.THIS INVENTION REFERS TO NEW CHEMICAL COMPOUNDS, (STRUCTURE THAT IS SHOWN AS "FORMULA I", STRUCTURE IS SCORED IN FOUR REGIONS FOR BETTER UNDERSTANDING, WHICH ARE SHOWN IN THE ORIGINAL RECORD). THESE COMPOUNDS FIND A PARTICULAR USE, EVEN IF NOT EXCLUSIVE, AS PHARMACEUTICAL COMPOUNDS, ESPECIALLY AS MODULATORS OF CCR5 CHEMIOKINES (CHEMOTOTIC CITOCINES). IT ALSO REFERS TO FORMULATIONS OR DOSAGE FORMS THAT INCLUDE THESE COMPOUNDS, TO THE USE OF THESE COMPOUNDS IN THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS OR DOSAGE FORMS, AND TO PROCESSING PROCEDURES, ESPECIALLY THE TREATMENT OF DISEASES AND PRE-DUCTION INFLUENCES FOR HIV1 AND GENETICALLY RELATED RETROVIRUS.

GT199900219A 1998-12-23 1999-12-22 CCR5 MODULATORS GT199900219A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9828420.1A GB9828420D0 (en) 1998-12-23 1998-12-23 CCR5 antagonists useful as anti-hiv agents

Publications (1)

Publication Number Publication Date
GT199900219A true GT199900219A (en) 2002-03-22

Family

ID=10844869

Family Applications (2)

Application Number Title Priority Date Filing Date
GT199900219A GT199900219A (en) 1998-12-23 1999-12-22 CCR5 MODULATORS
GT199900221A GT199900221A (en) 1998-12-23 1999-12-22 CCR5 MODULATORS

Family Applications After (1)

Application Number Title Priority Date Filing Date
GT199900221A GT199900221A (en) 1998-12-23 1999-12-22 CCR5 MODULATORS

Country Status (4)

Country Link
ES (1) ES2362711T3 (en)
GB (1) GB9828420D0 (en)
GT (2) GT199900219A (en)
ZA (2) ZA200104211B (en)

Also Published As

Publication number Publication date
ZA200104254B (en) 2002-11-01
GT199900221A (en) 2001-06-14
ZA200104211B (en) 2002-01-14
ES2362711T3 (en) 2011-07-12
GB9828420D0 (en) 1999-02-17

Similar Documents

Publication Publication Date Title
PA8488101A1 (en) CCR5 MODULATORS
BR9911488A (en) Compound, use of it, pharmaceutical composition, and processes for the treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound
DK1465626T3 (en) Pharmaceutical compositions (kits) comprising dihydropyridinone compounds and an immunoregulatory (or anti-inflammatory) agent and uses thereof
BR9907270A (en) Compound, pharmaceutical composition, use of a compound, and, processes for the treatment or prophylaxis of inflammatory diseases, for example, asthma or copd, and for the preparation of a compound
PA8487201A1 (en) CCR5 MODULATORS
BR9911482A (en) Compound, pharmaceutical composition, use of the compound, and, processes for the treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound
NO20024005D0 (en) Pteridine compounds for the treatment of psoriasis
BR9907886A (en) Compound, use of it, pharmaceutical composition, and, treatment process or prophylaxis of inflammatory diseases, for example asthma or copd.
BR9714082A (en) Compound, use thereof, pharmaceutical composition, and, processes for treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound.
BRPI0007487B8 (en) diphenyl-ureas substituted with w-carboxy-aryls as raf kinase inhibitors
GT200000014A (en) DERIVATIVES OF QUINOLIN - 2 - ONA SUBSTITUTED WITH HETEROARILO USEFUL AS ANTI-BANERIGAN AGENTS.
DOP2002000429A (en) IMIDAZOTRIAZINAS
BR0116052A (en) imidazoquinolines substituted by aryl ether
ID22746A (en) NEW COMPOUNDS
NO324227B1 (en) Cyclopropyl-fused pyrrolidine-based compounds, pharmaceutical compositions and combinations containing them as well as the use thereof for the manufacture of medicaments for the treatment of diseases
BR0313676A (en) Pyrimidine derivatives and their use as cb2 modulators
SE9903544D0 (en) Novel compounds
BR9708114A (en) Xanthone analogues for the treatment of infectious diseases.
ES2038650T3 (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL COMPOSITION INCLUDING 3'-DEOXYTIMIDIN-2'-ENO- (3'-DESOXI-2 ', 3'-DIDESHIDROTIMIDINA) TO TREAT PATIENTS INFECTED WITH RETROVIRUS.
DE60233261D1 (en) INHIBITORS OF HUMAN ADAM-10
SE9804212D0 (en) Compounds
SE9801494D0 (en) Novel use
ES2188908T3 (en) DERIVATIVES OF CIS-3,4-CROMANO USEFUL FOR THE PREVENTION OR TREATMENT OF SYNDROMES RELATED TO THE STROGENS.
ES2129893T3 (en) DINUCLEOSIDE-5 ', 5'-PYROPHOSPHATES.
PL1765337T3 (en) Combination of tenofovir, ritonavir and tmc114